Press Releases
Select a Month...
-
Seattle Children's Opens Immunotherapy Trial for Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain
6.19.18
CAR T-cell immunotherapy targeting HER2 protein on cancer cells aims to provide children and young adults who have limited treatment options with a second line...
-
CureWorks Collaborative Launches to Accelerate Development of Immunotherapy Treatments for Childhood Cancers, Increase Access to Clinical Trials
6.12.18
Seattle Children’s, Children’s National Health System, BC Children’s Hospital and Children's Hospital Los Angeles start international collaborative to expand...
-
Seattle Children’s Receives $60 Million Legacy Gift
2.13.18
The landmark bequest is the second largest single charitable gift in Seattle Children’s 111-year history
-
Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant
12.9.17
The drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell...
-
Brotman Baty Institute for Precision Medicine Launches in Seattle
12.6.17
The Brotman Baty Institute for Precision Medicine combines the research strengths and capabilities of UW Medicine, Fred Hutchinson Cancer Research Center and...
-
Seattle Children’s Opens First CAR T-Cell Immunotherapy Trial in the U.S. for Children and Young Adults With Leukemia That Targets CD22 and CD19 Proteins Simultaneously
11.16.17
By launching a bilateral attack on cancer cells, researchers hope to ultimately increase patients’ long-term remission
-
Seattle Children’s Launches $1 Billion Fundraising Campaign to Transform Children’s Health
11.15.17
It Starts With Yes: The Campaign for Seattle Children’s is the largest in Seattle Children’s 110-year history
-
Suzanne Beitel Appointed Senior Vice President, Chief Financial Officer of Seattle Children's
10.17.17
Beitel assumes role after serving as executive director in the Public Finance Group at JP Morgan
-
Dr. Zafar Chaudry Appointed Senior Vice President, Chief Information Officer of Seattle Children's
10.2.17
Chaudry assumes role after serving as chief information officer at Cambridge University Hospitals in the United Kingdom
-
Seattle Children's Opens CD22 CAR T-Cell Immunotherapy Trial for Children and Young Adults Whose Leukemia Escapes CD19 CAR T-Cell Therapy
7.27.17
Phase 1 trial aims to increase long-term remission, it is the first on the West Coast to target CD22-positive leukemia
